SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders focused on the November 22 target date and the companys amended application emphasizing upper-limb function data. Bullish traders interpret the longer-term data, rare-disease policy discussions and recent commercial hiring as encouraging signs, while skeptics cite prior FDA concerns and say approval remains uncertain.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could fall after early 2027 has fueled a sharp selloff and concern about future pricing and revenue. Traders disagree over whether the warning signals sustained pressure or is only a preliminary estimate, pointing to CMSs more stable outlook while criticizing CorMedixs lack of clarification.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

The rally toward fresh highs is drawing attention ahead of the expected Q3 report, with traders weighing BRIUMVIs growth against unconfirmed buyout speculation and possible short-covering. Some see the move as a bet on earnings and the companys commercial prospects rather than an acquisition; no deal has been confirmed.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs REGAL Phase 3 AML trial reaching its prespecified 80th death event has triggered final analysis, with topline results expected this quarter. Traders are divided over whether GPS improved survival: bullish holders see the pending readout as a major catalyst, while bears question the efficacy case, and the share-price decline has intensified debate about selling pressure and alleged short activity.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention after a sharp Nasdaq selloff tied to weakness in technology and semiconductor stocks, with traders debating whether concerns about AI spending and earnings justify more downside or whether the decline is an oversold dip to buy. The late-session rebound prompted some dip-buying optimism, but bearish traders continued to warn that the correction may not be over.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 76,874.98691422 USD and is down -4.82 over the last 24 hours. It is currently trading on 12773 active market(s) with $58,826,736,014.03 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

A reported major Binance security breach and temporary withdrawal suspension have fueled Bitcoin selling and concerns about crypto exchange security. Traders disagree over whether the incident signals broader risk or is isolated to Binance, with some viewing the pullback as a buying opportunity and others warning of further downside.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigens PAPZIMEOS commercial launch and stronger-than-expected quarterly results, including a move to profitability, are driving bullish discussion about its growth prospects. Traders also debate whether potential INO-3107 competition could challenge PAPZIMEOS and whether heavy short interest is amplifying the stocks moves.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is caught in a broader technology and semiconductor selloff as traders question whether massive AI infrastructure spending will generate adequate returns, with mixed Amazon and Intel results adding to sector concerns. The community is split between warnings that the AI trade may be overstretched and dip buyers who view the decline as a temporary pullback while AI demand remains strong.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

A strong third-quarter earnings beat, supported by growth in Eylea HD and Sanofi collaboration revenue tied to Dupixent, has driven a sharp move higher in REGN. Traders are broadly cheering the results and breakout, while some are watching for a pullback after the rally.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff ahead of its quarterly report is fueling concern about slowing ad growth, analyst target cuts, and weakness across advertising-related stocks. Traders debate whether the decline reflects deteriorating prospects or has overshot the companys growth and cash-generation fundamentals, with earnings seen as a key test.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NRC Approves Security Plan For NANO's Laser Enrichment Partner As SWU Spot Hit Record HIgh

NRC Approves Security Plan For NANO's Laser Enrichment Partner As SWU Spot Hit Record HIgh

 Last week the uranium showed up. This week Washington signed off on who gets to look at what happens to it.

On Thursday morning LIS Technologies (LIST), the private laser enrichment developer in...

Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Sept. 28, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or...

ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. Second Quarter 2026 and...

Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company

ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or ASPI), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, and ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or NDRA), a pioneer in thermoacoustic...

CRML, UUUU, ASPI, USAR In Focus: Report Questions Trump, Lutnick Family Ties To Government-Backed Critical Metal Projects 

Equity

Concerns have been raised about companies pursuing more than $8.9 billion in federal support. 


ASP Isotopes To Merge Noble Africa With A Unit Of ENDRA – A Look At The Key Contours Of The Deal

ASP Isotopes is expected to own approximately 89% of the combined company, with ENDRA shareholders owning 3%.

ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing

ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes," ASPI or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, and ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or NDRA), a pioneer in...

ASP Isotopes's Tetra4 Secures First Helium Sales Contract

(RTTNews) - ASP Isotopes Inc. (ASPI), an advanced materials company, Tuesday announced that its subsidiary Renergen Limited whose principal asset is its 94.5 percent equity ownership in Tetra4 Proprietary Limited has secured its first contract for the sale of liquid helium...

ASPI Stock Heads For Best Gains In 7 Months – Why Are Investors Excited About ASP Isotopes Restarting Its Silicon Facility?

ASP Isotopes said that during a customer site visit in the second half of last year, it began implementing numerous modifications to non-core elements of the facility, such as valves, compressors, and piping. 


ASP Isotopes Soars On Restart Of Silicon-28 Facility, Locks In Q3 2026 Commercial Shipments

ASP Isotopes Soars On Restart Of Silicon-28 Facility, Locks In Q3 2026 Commercial Shipments

 ASP Isotopes cleared a major operational milestone at its Pretoria Silicon-28 enrichment facility, restarting the first 18 stages, and has now run them for over three weeks at target enrichment...

ASP Isotopes, Inc. is developing a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. It operates through the following segments: Nuclear Fuels, Specialist Isotopes and Related Services, and Helium and LNG. The Nuclear Fuels segment engages in the research and development of technologies and methods for producing HALEU and Lithium-6 for the advanced nuclear fuels target market, including the operations of QLE. The Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods for the separation of high-value, low-volume isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.

ASP Isotopes Inc

Neutral Sentiment

<ul class="summary-bullets"><li>The Kazakhstan project has drawn scrutiny because firms linked to Trump's and Lutnick's sons participated in related transactions.</li><li>Public filings show at least 14 companies with ties to the families have received or are seeking more than $8.9 billion in federal support.&nbsp;</li><li>The report also said Democratic lawmakers have called for an investigation into potential conflicts of interest.&nbsp;&nbsp;</li></ul>The Trump administration’s effort to strengthen U.S. access to critical minerals has reportedly become the focus of political and ethical debate after investments linked to senior officials' family members overlapped with government-backed mining initiatives.&nbsp;Critical Metals (CRML), Energy Fuels (UUUU), USA Rare Earth (USAR), and ASP Isotopes (ASPI) are drawing attention due to conflicts of interest.<h2 class="st-heading-2">China Supply Concerns Drive U.S. Mining Push&nbsp;</h2>President Donald Trump and Commerce Secretary Howard Lutnick helped secure an agreement with Kazakhstan in late 2025 that gives an American-led venture access to one of the world's largest undeveloped tungsten deposits.&nbsp;The project, led by Kaz Resources, is eligible for up to $1.6 billion in potential federal financing through U.S. government agencies, subject to additional approvals.The Kazakhstan project is part of Washington's broader effort to diversify supplies of critical minerals used in defense systems, semiconductor manufacturing, and aerospace production. China's dominant role in the global tungsten market and its export restrictions on several strategic minerals has accelerated U.S. efforts to establish alternative supply chains.<h2 class="st-heading-2">Trump And Lutnick Family Ties Examined&nbsp;</h2>According to The New York Times&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.nytimes.com/2026/06/28/world/europe/trump-lutnick-sons-kazakhstan.html">report</a>, the deal has attracted attention because financial firms connected to the sons of Trump and Lutnick became involved in related corporate transactions while the project was advancing.Donald Trump Jr. and Eric Trump serve as advisers to Dominari Holdings (DOMH), which participated in an investment vehicle tied to the Kazakhstan venture. A corporate transaction involving Skyline Builders, later restructured into Kaz Resources through a reverse merger, ultimately provided investors with exposure to the mining project before commercial production begins, said the report.Meanwhile, Cantor Fitzgerald, the investment bank formerly led by Howard Lutnick and now overseen by his sons Brandon and Kyle Lutnick, acted as a fundraising adviser for ASP Isotopes, a company connected to one of the project's principal investors.&nbsp;The capital raise totaled approximately $210 million, generating customary advisory fees for the firm.Public filings indicate that companies with financial relationships involving either the Trump or Lutnick families have participated in numerous critical-minerals projects receiving federal backing.&nbsp;According to the report, at least 14 companies, including Critical Metals, Energy Fuels, USA Rare Earth, and ASP Isotopes, have obtained or are seeking more than $8.9 billion in government loans, financing commitments, grants, or other forms of assistance.USA Rare Earth has received significant federal support for domestic rare-earth processing while also working with Cantor Fitzgerald on fundraising initiatives.&nbsp;While&nbsp;<a href="https://stocktwits.com/symbol/CRML">Critical Metals</a> and&nbsp;<a href="https://stocktwits.com/symbol/UUUU">Energy Fuels</a> stocks edged lower by 0.9% and 0.2% respectively,&nbsp;<a href="https://stocktwits.com/symbol/USAR">USA Rare Earth</a>, and&nbsp;<a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes</a> stocks climbed between 1% and 2% in Monday’s premarket.&nbsp;Democratic lawmakers and ethics advocates have questioned whether family investment activities created the appearance of conflicts of interest. Democratic representative Maxine Dexter has called for congressional oversight to ensure taxpayer-supported mining initiatives primarily serve national interests rather than individuals with close ties to administration officials.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bb-stock-gains-premarket-analysts-turn-more-optimistic-on-growth-outlook-following-q1-beat/cZ19cTkR7hg">BB Stock Gains Premarket: Analysts Turn More Optimistic On Growth Outlook Following Q1 Beat</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Critical Metals Corp. logo is seen displayed on a smartphone screen

The Trump administration’s effort to strengthen U.S. access to critical minerals has reportedly become the focus of political and ethical debate after investments linked to senior officials' family members overlapped with government-backed mining initiati

Critical Metals Corp.

USA Rare Earth Inc

Energy Fuels Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$2.02
Prev Close	$2.13
Open	$2.02
Dividend Yield	0.00%
50-Day Moving Average	$3.02
Beta	2.71
Avg. Volume	4.56M
PE Ratio	-1.62

52-Week High	$10.76
52-Week Low	$1.89
Market Capitalization	$326.55M
EPS (Annual)	-$2.11
Price to Book	1.05
Revenue Per Employee	$88,003.69

Feed

News

Sentiment

Earnings

Fundamentals

Info

ASPI Fundamentals